MétaCan
Menu
Back to cohort

Adherence to guidelines for adjuvant chemotherapy (AC) use in stage II colon cancer (CC).

2012· article· en· W2590756575 on OpenAlexaff
Winson Y. Cheung, Howard J. Lim, Daniel J. Renouf, Ryan Woods, Caroline Speers

Bibliographic record

VenueJournal of Clinical Oncology · 2012
Typearticle
Languageen
FieldMedicine
TopicColorectal Cancer Treatments and Studies
Canadian institutionsPrincess Margaret Cancer CentreBC Cancer Agency
Fundersnot available
KeywordsMedicinePerineural invasionInternal medicineStage (stratigraphy)Lymphovascular invasionOncologyPopulationProportional hazards modelCancerGuidelineConcordancePathologyMetastasis

Abstract

fetched live from OpenAlex

169 Background: Treatment guidelines suggest that AC may be considered inpatients (pts) with "high risk" stage II CC, defined by the presence of >/=1 poor prognostic features, such as obstruction or perforation, T4 stage, <12 lymph nodes retrieved, positive resection margins, and lymphovascular or perineural invasion. However, survival benefits associated with AC use in high risk pts remain largely unproven. Therefore, current recommendations are primarily driven by consensus rather than by evidence. Our aims were to examine population-based concordance with current guidelines for AC use in stage II CC and to explore the relationship between AC use and survival in high- vs. low-risk pts. Methods: All pts diagnosed with stage II CC in British Columbia from 1999 to 2008 and evaluated at 1 of 5 regional cancer centers were reviewed. Kaplan-Meier and Cox regression methods were used to correlate high- vs. low-risk status as well as receipt of AC with relapse-free (RFS), disease specific (DSS), and overall survival (OS). Results: We identified 1,697 stage II CC pts: 1,236 (73%) high risk and 461 (27%) low risk among whom only 363 (29%) and 61 (13%) received AC, respectively. Individuals with high risk features who received guideline-concordant AC were younger (median 62 vs. 72 years, p<0.001) and had better performance status (ECOG 0/1 47% vs. 34%, p=0.02). In the high-risk group, AC was associated with improved 5-year OS, but not with RFS or DSS. After adjusting for confounders, an OS advantage from AC persisted for high-risk pts (HR 0.67, 95 CI 0.52-0.86, p=0.002), but no significant RFS or DSS benefits were seen (HR 0.76, 95 CI 0.58-0.99, p=0.05 and HR 0.75, 95 CI 0.55-1.02, p=0.11, respectively). Subgroup analyses showed that only individuals with T4 lesions had improved RFS (HR 0.63, 95 CI 0.42-0.95, p=0.03), DSS (HR 0.59, 95 CI 0.37-0.93, p=0.02), and OS (HR 0.50, 95 CI 0.33-0.77, p=0.002). Conclusions: In this population-based cohort of stage II CC patients, less than one-third of high risk patients received guideline-concordant AC. Consistent survival benefits were only seen in those with T4 lesions, suggesting a very limited role for AC. Guidelines that are mainly consensus-driven and associated with minimal survival benefits have poor uptake.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.010
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.157
Threshold uncertainty score0.311

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.010
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.495
GPT teacher head0.600
Teacher spread0.105 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicColorectal Cancer Treatments and StudiesFrench-language works237,207